NIGMS will accept the submission of applications for Competitive Revisions to active grants to address only the following research areas of interest:
Incorporation of data related to SARS-CoV-2 into ongoing research efforts to develop predictive models for the spread of SARS-CoV-2 and other related infectious agents (all relevant grants).
Repurposing or modification of diagnostic tools currently under development to enable rapid detection of SARS-CoV-2 infection (SBIR/STTR grants only).
Rapid development of potential therapeutic agents for COVID-19 (SBIR/STTR only).